Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

ADMA

Adma Biologics Inc

Apr 18 • 04:00PM ET

6.20

Dollar change +0.16
Percentage change 2.65	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IBB DWAS SCHA IWO IWN VTWO VHT

Index	RUT	P/E	-	EPS (ttm)	-0.13	Insider Own	3.82%	Shs Outstand	226.06M	Perf Week	-0.32%
Market Cap	1.44B	Forward P/E	12.40	EPS next Y	0.50	Insider Trans	-14.68%	Shs Float	222.93M	Perf Month	0.16%
Income	-28.24M	PEG	-	EPS next Q	0.06	Inst Own	73.17%	Short Float	3.27%	Perf Quarter	23.51%
Sales	258.21M	P/S	5.57	EPS this Y	326.92%	Inst Trans	7.41%	Short Ratio	2.87	Perf Half Y	80.23%
Book/sh	0.60	P/B	10.37	EPS next Y	69.49%	ROA	-8.33%	Short Interest	7.29M	Perf Year	85.63%
Cash/sh	0.22	P/C	27.98	EPS next 5Y	-	ROE	-19.67%	52W Range	3.06 - 6.76	Perf YTD	37.17%
Dividend Est.	-	P/FCF	356.57	EPS past 5Y	38.68%	ROI	-10.25%	52W High	-8.28%	Beta	0.45
Dividend TTM	-	Quick Ratio	1.69	Sales past 5Y	73.26%	Gross Margin	34.16%	52W Low	102.61%	ATR (14)	0.23
Dividend Ex-Date	-	Current Ratio	5.16	EPS Y/Y TTM	62.29%	Oper. Margin	8.38%	RSI (14)	52.30	Volatility	4.37% 3.65%
Employees	624	Debt/Eq	1.05	Sales Y/Y TTM	67.59%	Profit Margin	-10.94%	Recom	1.00	Target Price	8.38
Option/Short	Yes / Yes	LT Debt/Eq	1.04	EPS Q/Q	-29.52%	Payout	-	Rel Volume	1.17	Prev Close	6.04
Sales Surprise	2.47%	EPS Surprise	-420.00%	Sales Q/Q	47.86%	Earnings	Feb 28 AMC	Avg Volume	2.54M	Price	6.20
SMA20	-1.45%	SMA50	5.34%	SMA200	39.36%	Trades		Volume	2,981,156	Change	2.65%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-23	Resumed	Raymond James	Strong Buy	$5
Oct-13-22	Initiated	Mizuho	Buy	$5
Nov-11-21	Upgrade	Raymond James	Outperform → Strong Buy	$5
Nov-09-21	Initiated	Cantor Fitzgerald	Overweight	$4.50
Jun-04-19	Initiated	Jefferies	Buy	$8
Apr-15-19	Reiterated	H.C. Wainwright	Buy	$10 → $13
Feb-07-19	Resumed	H.C. Wainwright	Buy	$10
Dec-11-17	Reiterated	Maxim Group	Buy	$13 → $8
Nov-14-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-23-17	Upgrade	Maxim Group	Hold → Buy	$13
Aug-01-16	Downgrade	Maxim Group	Buy → Hold
Jul-25-16	Reiterated	Maxim Group	Buy	$24 → $14
May-13-15	Reiterated	Maxim Group	Buy	$18 → $24
Dec-08-14	Initiated	Oppenheimer	Outperform	$20
Dec-01-14	Reiterated	Maxim Group	Buy	$16 → $18

Show Previous Ratings

Apr-17-24 05:50PM	Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Apr-10-24 05:45PM	Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Apr-09-24 11:07AM	Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now? (Zacks)
Apr-05-24 08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Apr-01-24 05:50PM	Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
05:50PM	Loading…
Mar-22-24 05:50PM	Why the Market Dipped But Adma Biologics (ADMA) Gained Today (Zacks)
Mar-20-24 08:50AM	Recent Price Trend in ADMA Biologics (ADMA) is Your Friend, Here's Why (Zacks)
Mar-18-24 09:55AM	Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 33.56%: Read This Before Placing a Bet (Zacks)
09:30AM	Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest? (Zacks)
Mar-15-24 05:50PM	Adma Biologics (ADMA) Stock Moves -0.5%: What You Should Know (Zacks)
Mar-11-24 07:00AM	ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV & BIVIGAM (GlobeNewswire)
Mar-05-24 12:00PM	Adma Biologics (ADMA) Is Up 4.94% in One Week: What You Should Know (Zacks)
07:00AM	ADMA Biologics to Participate in the Raymond James Institutional Investor Conference (GlobeNewswire)
Mar-04-24 08:50AM	Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Mar-01-24 09:55AM	Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 28.36%: Here's is How to Trade (Zacks)
09:30AM	Loading…
09:30AM	Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? (Zacks)
Feb-29-24 11:06AM	ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:37AM	Q4 2023 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 05:30PM	Adma Biologics: Q4 Earnings Snapshot (Associated Press Finance)
04:42PM	ADMA Biologics Inc Reports Robust Revenue Growth and Positive Adjusted Net Income for FY 2023 (GuruFocus.com)
04:10PM	ADMA Biologics Announces CFO Transition (GlobeNewswire)
04:05PM	ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-22-24 05:45PM	Adma Biologics (ADMA) Gains But Lags Market: What You Should Know (Zacks)
Feb-21-24 05:50PM	Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
04:05PM	ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
07:00AM	ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics (GlobeNewswire)
Feb-15-24 05:45PM	Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider (Zacks)
08:50AM	Here's Why Momentum in Adma Biologics (ADMA) Should Keep going (Zacks)
Feb-07-24 05:45PM	Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Feb-06-24 09:30AM	Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
09:55AM	Loading…
Feb-05-24 09:55AM	Does Adma Biologics (ADMA) Have the Potential to Rally 31.55% as Wall Street Analysts Expect? (Zacks)
Feb-02-24 05:50PM	Adma Biologics (ADMA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-30-24 08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jan-19-24 09:55AM	Wall Street Analysts Predict a 27.09% Upside in Adma Biologics (ADMA): Here's What You Should Know (Zacks)
Jan-17-24 09:30AM	Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet (Zacks)
Jan-10-24 08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jan-08-24 07:00AM	ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update (GlobeNewswire) +9.32%
Jan-05-24 12:00PM	Are You Looking for a Top Momentum Pick? Why Adma Biologics (ADMA) is a Great Choice (Zacks)
Dec-26-23 09:30AM	Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? (Zacks)
Dec-25-23 09:55AM	Should You Buy Adma Biologics (ADMA) After Golden Cross? (Zacks)
Dec-18-23 04:05PM	ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management (GlobeNewswire)
Dec-12-23 07:00AM	ADMA Biologics Announces FDA Approval for BIVIGAM in the Pediatric Patient Setting for Those 2 Years of Age and Older (GlobeNewswire)
Dec-08-23 09:30AM	Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? (Zacks)
Dec-06-23 09:40AM	Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? (Zacks)
Nov-22-23 09:30AM	Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Nov-17-23 06:29PM	Why Adma Biologics Stock Crushed the Market on Friday (Motley Fool)
Nov-16-23 07:00AM	ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD (GlobeNewswire)
Nov-10-23 11:05AM	ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:25PM	Why Adma Biologics Was Trouncing the Market Today (Motley Fool) +5.80%
10:04AM	Q3 2023 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 04:49PM	Adma Biologics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-06-23 09:30AM	Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? (Zacks)
Nov-02-23 05:45PM	Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Nov-01-23 07:00AM	ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023 (GlobeNewswire)
Oct-27-23 05:45PM	Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note (Zacks)
Oct-25-23 05:50PM	Adma Biologics (ADMA) Stock Moves -0.94%: What You Should Know (Zacks)
Oct-17-23 05:50PM	Adma Biologics (ADMA) Rises As Market Takes a Dip: Key Facts (Zacks)
Oct-09-23 05:50PM	Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why (Zacks)
Sep-29-23 09:30AM	Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Sep-27-23 05:50PM	Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know (Zacks)
Sep-21-23 05:50PM	Adma Biologics (ADMA) Gains As Market Dips: What You Should Know (Zacks)
Sep-14-23 05:50PM	Adma Biologics (ADMA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Sep-13-23 09:30AM	Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? (Zacks)
Aug-10-23 02:31PM	Why Shares of ADMA Biologics Are Climbing Thursday (Motley Fool) +6.16%
11:50AM	ADMA Biologics, Inc.'s (NASDAQ:ADMA) Profit Outlook (Simply Wall St.)
09:40AM	Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? (Zacks)
06:46AM	Q2 2023 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-09-23 06:40PM	Adma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:37PM	Adma Biologics: Q2 Earnings Snapshot (AP Finance)
04:05PM	ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-02-23 07:00AM	ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023 (GlobeNewswire)
Jul-28-23 08:59AM	ADMA Biologics (ADMA) to Report Q2 Earnings: What's in Store? (Zacks)
Jul-26-23 11:30AM	2 Biotech Stocks to Watch as Their Growth Stories Brighten (TheStreet.com)
Jul-25-23 05:12PM	Load Up, Says Raymond James About These 2 Strong Buy Stocks (TipRanks)
Jul-20-23 05:50PM	Adma Biologics (ADMA) Gains As Market Dips: What You Should Know (Zacks)
Jul-19-23 07:00AM	ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA (GlobeNewswire)
Jul-13-23 05:50PM	Adma Biologics (ADMA) Gains But Lags Market: What You Should Know (Zacks)
Jul-07-23 07:32AM	New Strong Buy Stocks for July 7th (Zacks)
Jun-23-23 10:31AM	Aeglea (AGLE) Soars 329% on Acquiring Spyre Therapeutics (Zacks)
Jun-22-23 09:18AM	Alderya (ALDX) Stock Declines on Getting CRL for PVRL Candidate (Zacks)
Jun-21-23 03:21PM	Denali (DNLI) Provides Update on Hunter Syndrome Study (Zacks)
10:46AM	Merck's (MRK) Gastric Cancer Study Fails to Meet a Primary Goal (Zacks)
Jun-19-23 10:28AM	Reata (RETA) Announces FDA's Acceptance of Skyclarys PAS (Zacks)
Jun-16-23 10:43AM	Mersana (MRSN) Down on Partial Ovarian Cancer Study Hold (Zacks)
10:26AM	Aldeyra (ALDX) Up On Positive Data From Conjunctivitis Study (Zacks)
Jun-14-23 12:17PM	Can-Fite (CANF) Up on Namodenoson Progress in Pancreatic Cancer (Zacks)
11:48AM	Recursion (RXRX) Up on Completing REC-994 Study Enrollment (Zacks)
09:40AM	Is InMode (INMD) Outperforming Other Medical Stocks This Year? (Zacks)
Jun-13-23 09:18AM	Ironwood (IRWD), AbbVie Get FDA Nod for Linzess Label Expansion (Zacks)
Jun-08-23 11:49AM	Timber (TMBR) Surges on Carcinogenicity Waiver for TMB-001 (Zacks)
11:20AM	AVITA (RCEL) Gets FDA Nod for Expanded Use of RECELL System (Zacks)
Jun-07-23 12:31PM	Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View (Zacks)
Jun-06-23 11:14AM	Ultragenyx (RARE) Posts Data From Osteogenesis Imperfecta Study (Zacks)
Jun-05-23 12:43PM	BioNTech (BNTX) Up on Initial Data From Lung Cancer Antibody (Zacks)
10:22AM	Bristol Myers (BMY) Announces Upbeat Data From NSCLC Study (Zacks)
Jun-02-23 10:59AM	LAVA (LVTX) Up on J&J's (JNJ) Cancer Study Candidate Selection (Zacks)
Jun-01-23 11:59AM	Genprex (GNPX) Up on Advancing Early-Stage NSCLC Study (Zacks)
May-31-23 10:46AM	J&J (JNJ) Submits NDA for Single Tablet Combo to Treat PAH (Zacks)
May-30-23 10:56AM	Lexicon's (LXRX) Heart Failure Drug Inpefa Gets FDA Approval (Zacks)

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ELMS STEVE	Director	Mar 19 '24	Sale	6.08	411,829	2,503,920	2,115,671	Mar 19 09:48 PM
ELMS STEVE	Director	Mar 18 '24	Sale	6.01	49,887	299,821	2,527,500	Mar 19 09:48 PM
ELMS STEVE	Director	Mar 15 '24	Sale	6.01	183,008	1,099,878	2,577,387	Mar 15 09:00 PM
ELMS STEVE	Director	Mar 14 '24	Sale	6.05	448,276	2,712,070	2,760,395	Mar 15 09:00 PM
ELMS STEVE	Director	Mar 13 '24	Sale	6.21	407,000	2,527,470	3,208,671	Mar 15 09:00 PM
Grossman Jerrold B	Director	Aug 30 '23	Buy	3.71	130,000	482,144	443,265	Aug 30 04:58 PM
KWON YOUNG	Director	Aug 24 '23	Buy	3.90	25,000	97,500	277,401	Aug 24 07:53 PM
Fong Bryant	Director	Aug 22 '23	Sale	3.87	1,433,304	5,544,737	0	Aug 23 08:30 PM
Grossman Adam S	President and CEO	Aug 18 '23	Sale	4.15	250,000	1,038,350	2,273,085	Aug 18 09:46 PM
LENZ BRIAN	EVP, CFO	Aug 16 '23	Sale	4.45	178,184	793,400	782,013	Aug 17 09:30 PM
Grossman Adam S	President and CEO	Aug 16 '23	Sale	4.38	3	13	2,523,085	Aug 17 09:30 PM
Grossman Adam S	President and CEO	Aug 15 '23	Option Exercise	3.11	2,100,459	6,536,448	4,623,544	Aug 17 09:30 PM
LENZ BRIAN	EVP, CFO	Aug 15 '23	Option Exercise	3.11	809,262	2,514,363	1,591,275	Aug 17 09:30 PM
Grossman Adam S	President and CEO	Aug 15 '23	Sale	4.54	510,469	2,318,959	4,113,075	Aug 17 09:30 PM
LENZ BRIAN	EVP, CFO	Aug 15 '23	Sale	4.60	211,578	972,730	782,013	Aug 17 09:30 PM

Open in Screener

CMRX

Chimerix Inc

Apr 18 • 04:00PM ET

0.9323

Dollar change +0.0283
Percentage change 3.13	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC GERM

Index	-	P/E	-	EPS (ttm)	-0.93	Insider Own	11.04%	Shs Outstand	88.93M	Perf Week	-5.83%
Market Cap	83.17M	Forward P/E	-	EPS next Y	-0.96	Insider Trans	0.14%	Shs Float	79.36M	Perf Month	-2.89%
Income	-82.09M	PEG	-	EPS next Q	-0.22	Inst Own	46.03%	Short Float	1.56%	Perf Quarter	1.30%
Sales	0.32M	P/S	259.91	EPS this Y	8.76%	Inst Trans	-1.71%	Short Ratio	2.93	Perf Half Y	-10.36%
Book/sh	2.17	P/B	0.43	EPS next Y	-12.63%	ROA	-33.36%	Short Interest	1.24M	Perf Year	-24.20%
Cash/sh	2.05	P/C	0.45	EPS next 5Y	-	ROE	-36.50%	52W Range	0.88 - 1.57	Perf YTD	-3.14%
Dividend Est.	-	P/FCF	-	EPS past 5Y	8.31%	ROI	-42.24%	52W High	-40.62%	Beta	1.13
Dividend TTM	-	Quick Ratio	10.25	Sales past 5Y	292.67%	Gross Margin	98.98%	52W Low	5.94%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	10.25	EPS Y/Y TTM	-147.20%	Oper. Margin	-28723.77%	RSI (14)	38.02	Volatility	5.81% 5.79%
Employees	72	Debt/Eq	0.01	Sales Y/Y TTM	-99.04%	Profit Margin	-25337.96%	Recom	1.29	Target Price	7.00
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	14.16%	Payout	-	Rel Volume	0.85	Prev Close	0.90
Sales Surprise	-95.12%	EPS Surprise	15.15%	Sales Q/Q	-99.51%	Earnings	Feb 29 BMO	Avg Volume	423.93K	Price	0.93
SMA20	-6.01%	SMA50	-13.15%	SMA200	-9.44%	Trades		Volume	361,015	Change	3.13%

Date	Action	Analyst	Rating Change	Price Target Change
May-23-23	Initiated	Robert W. Baird	Outperform	$7
Sep-07-22	Initiated	CapitalOne	Overweight	$7
Apr-29-21	Initiated	Maxim Group	Buy	$20
Apr-23-21	Resumed	Cowen	Outperform	$10 → $18
Mar-31-21	Initiated	Wedbush	Outperform	$21
Mar-31-21	Initiated	Jefferies	Buy	$21
Feb-14-18	Downgrade	JP Morgan	Neutral → Underweight
Feb-02-18	Initiated	H.C. Wainwright	Buy	$10
Aug-09-16	Reiterated	FBR Capital	Mkt Perform	$9 → $8
Feb-23-16	Reiterated	FBR Capital	Mkt Perform	$14 → $10
Feb-23-16	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Feb-23-16	Downgrade	Barclays	Overweight → Equal Weight	$12 → $6
Feb-22-16	Downgrade	Citigroup	Buy → Neutral
Dec-29-15	Downgrade	JP Morgan	Overweight → Neutral	$65 → $15
Dec-28-15	Reiterated	Piper Jaffray	Overweight	$63 → $10
Dec-28-15	Downgrade	FBR Capital	Outperform → Mkt Perform	$73 → $14
Dec-17-15	Initiated	UBS	Buy	$55
Oct-05-15	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Sep-03-15	Initiated	Citigroup	Buy
Aug-18-15	Initiated	FBR Capital	Outperform	$73

Show Previous Ratings

Apr-16-24 04:05PM	Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-21-24 07:00AM	Chimerix Appoints Marc D. Kozin to Board of Directors (GlobeNewswire)
Mar-01-24 09:06AM	Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 11:25PM	Q4 2023 Chimerix Inc Earnings Call (Thomson Reuters StreetEvents) -7.26%
08:11AM	Chimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results (GuruFocus.com)
07:27AM	Loading…
07:27AM	Chimerix: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Feb-27-24 07:00AM	Chimerix to Present at TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-22-24 07:00AM	Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024 (GlobeNewswire)
Dec-29-23 07:00AM	Chimerix Appoints Lisa Decker to Board of Directors (GlobeNewswire)
Dec-04-23 07:00AM	Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer (GlobeNewswire)
Nov-24-23 07:00AM	Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-16-23 07:00AM	Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer (GlobeNewswire)
Nov-03-23 09:12AM	Chimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call Transcript (Insider Monkey) +8.16%
01:34AM	Q3 2023 Chimerix Inc Earnings Call (Thomson Reuters StreetEvents)
10:08AM	Loading…
Nov-02-23 10:08AM	Chimerix Inc (CMRX) Reports Q3 2023 Financial Results and Operational Updates (GuruFocus.com)
07:10AM	Chimerix: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Oct-26-23 07:00AM	Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023 (GlobeNewswire)
Oct-23-23 10:08AM	12 Best Penny Stocks to Buy Under $1 (Insider Monkey)
Sep-05-23 07:00AM	Chimerix to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-16-23 10:05AM	Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery" (GlobeNewswire)
Aug-11-23 06:15AM	CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague. (InvestorPlace)
Aug-03-23 08:25AM	Chimerix (CMRX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:19AM	Chimerix: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Jul-31-23 07:54AM	10 Best Growth Stocks for the Next 10 Years (Insider Monkey)
Jul-30-23 02:17PM	7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes (InvestorPlace)
Jul-28-23 04:19PM	10 Best Rated Penny Stocks to Buy According to Analysts (Insider Monkey)
Jul-27-23 10:53AM	With 51% ownership, Chimerix, Inc. (NASDAQ:CMRX) boasts of strong institutional backing (Simply Wall St.)
07:00AM	Loading…
07:00AM	Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023 (GlobeNewswire)
06:00AM	7 Small-Cap Stocks to Buy Before the Breakout (InvestorPlace)
Jul-11-23 08:53PM	Why These 7 Stocks Are the Best Ways to Play Biotech Right Now (InvestorPlace)
Jun-28-23 02:58PM	Durham drugmaker Chimerix names new CEO at pivotal time (American City Business Journals)
Jun-27-23 04:05PM	Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer (GlobeNewswire)
Jun-01-23 08:04PM	7 Deeply Undervalued Growth Stocks to Buy in June (InvestorPlace)
May-31-23 04:01PM	Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference (GlobeNewswire)
May-25-23 07:00AM	Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House (GlobeNewswire) -5.56%
May-05-23 06:11AM	Chimerix First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
May-04-23 08:25AM	Chimerix (CMRX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:17AM	Chimerix: Q1 Earnings Snapshot (AP Finance)
07:00AM	Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Apr-27-23 07:00AM	Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023 (GlobeNewswire)
Apr-18-23 04:01PM	Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting (GlobeNewswire)
Mar-29-23 10:13AM	12 Cheap Healthcare Stocks to Buy in 2023 (Insider Monkey)
09:35AM	Chimerix (CMRX) Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-06-23 05:51AM	Chimerix, Inc. (NASDAQ:CMRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-03-23 06:57PM	The Top 7 Growth Stocks in Biotech (InvestorPlace)
Mar-02-23 10:10PM	Q4 2022 Chimerix Inc Earnings Call (Thomson Reuters StreetEvents) +6.29%
07:00AM	Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update (GlobeNewswire)
Feb-28-23 04:05PM	Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference (GlobeNewswire)
Feb-23-23 07:00AM	Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023 (GlobeNewswire)
Feb-17-23 09:04AM	With 53% ownership of the shares, Chimerix, Inc. (NASDAQ:CMRX) is heavily dominated by institutional owners (Simply Wall St.)
Feb-13-23 05:55PM	7 Overlooked Value Stocks That Could Outperform the Market (InvestorPlace)
Feb-07-23 01:51PM	The 7 Best Biotech Stocks to Buy for February 2023 (InvestorPlace)
Feb-02-23 02:19PM	The 7 Most Undervalued Biotech Stocks to Buy in February 2023 (InvestorPlace)
Jan-19-23 10:49AM	16 Stocks with the Lowest PE Ratio (Insider Monkey)
Jan-05-23 07:00AM	Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-27-22 02:53PM	2022 Year in Review: Layoffs hit Triangle biotech, pharma companies (American City Business Journals) -6.52%
Dec-12-22 01:41PM	Durham drugmaker to cut workforce by 25%, focus on new cancer drug (American City Business Journals)
Dec-08-22 05:00PM	Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update (GlobeNewswire)
Nov-29-22 12:00PM	Chimerix (CMRX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Nov-10-22 04:30PM	Chimerix Responds to Rubric Capital Management (GlobeNewswire) +14.92%
09:00AM	Rubric Capital Management Sends Letter to Chimerix Board of Directors (Business Wire)
Nov-07-22 06:06AM	Zacks.com featured highlights Chimerix, Vista Oil & Gas and Arcus Biosciences (Zacks) +7.18%
Nov-04-22 12:27PM	Durham drugmaker eyes potential roadmap to profitability after $238M deal (American City Business Journals)
07:46AM	Buy 3 of the Best Stocks by Using Net Income Ratio (Zacks)
Nov-03-22 08:15AM	Chimerix (CMRX) Beats Q3 Earnings Estimates (Zacks)
07:00AM	Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-01-22 10:01AM	Perrigo (PRGO) Earnings Expected to Grow: Should You Buy? (Zacks) +6.21%
Oct-27-22 04:30PM	Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022 (GlobeNewswire)
10:02AM	Chimerix (CMRX) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-26-22 11:52AM	Boston Scientific (BSX) Q3 Earnings Miss, Operating Margin Up (Zacks)
Sep-27-22 09:59PM	Durham pharma nets $238M for smallpox drug with more payouts lined up (American City Business Journals)
02:52PM	Emergent BioSolutions closes acquisition of smallpox drug from Chimerix (American City Business Journals)
10:13AM	Emergent (EBS) Acquires Worldwide Rights to Smallpox Antiviral (Zacks)
Sep-26-22 04:05PM	Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions (GlobeNewswire)
Sep-10-22 09:16AM	Institutional investors own a significant stake of 49% in Chimerix, Inc. (NASDAQ:CMRX) (Simply Wall St.)
Sep-06-22 07:00AM	Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire) -6.31%
Sep-01-22 08:48AM	Implied Volatility Surging for Chimerix (CMRX) Stock Options (Zacks)
Aug-30-22 02:17PM	Durham pharma locks down $680M deal with drug suddenly in high demand (American City Business Journals)
Aug-29-22 10:45AM	Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox (GlobeNewswire) +7.87%
Aug-17-22 09:29AM	7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher (InvestorPlace)
Aug-09-22 04:00AM	Chimerix (CMRX) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-08-22 04:01PM	Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update (GlobeNewswire) -11.94%
07:00AM	Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs (GlobeNewswire)
Aug-02-22 07:00AM	Chimerix to Present at Wedbush PacGrow Healthcare Conference (GlobeNewswire)
Aug-01-22 04:01PM	Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Update on August 8, 2022 (GlobeNewswire)
Jul-25-22 04:30PM	Siga, Peers Rise on Optimism Over Monkeypox Therapies (Bloomberg) +10.87%
09:42AM	WHO declares Monkeypox a global health emergency (Yahoo Finance Video)
Jul-16-22 09:45AM	Is Chimerix (NASDAQ:CMRX) In A Good Position To Invest In Growth? (Simply Wall St.)
Jun-24-22 03:08PM	As monkeypox spreads, Durham firm getting plenty of attention (American City Business Journals) +13.19%
10:37AM	Chimerix gets up to $25.3 mln contract from Canada for smallpox drug (Reuters)
10:06AM	Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada (GlobeNewswire)
Jun-23-22 09:15AM	Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement (GlobeNewswire) +12.35%
Jun-22-22 07:00AM	7 Penny Stocks That Could Triple in 2022 (InvestorPlace)
Jun-16-22 09:10AM	Insiders who bought stock earlier this year lose -US$93k as Chimerix, Inc. (NASDAQ:CMRX) drops to US$120m (Simply Wall St.)
Jun-09-22 06:28AM	7 Monkeypox Stocks That May Take Off in Q2 (InvestorPlace) -5.56%
Jun-01-22 04:30PM	Chimerix to Present at Jefferies Global Healthcare Conference (GlobeNewswire)
May-24-22 08:04AM	Triangle market caps keep tanking Duke economist explains the volatility (American City Business Journals) -22.98%

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jakeman David	VP OF FINANCE AND ACCOUNTING	Feb 14 '24	Sale	1.04	2,660	2,777	141,232	Feb 16 08:00 PM
LaSpaluto Michelle	CHIEF FINANCIAL OFFICER	Feb 14 '24	Sale	1.04	1,940	2,023	110,999	Feb 16 08:01 PM
Andriole Michael T.	PRESIDENT AND CEO	Feb 14 '24	Sale	1.04	1,744	1,809	447,021	Feb 16 08:02 PM
MIDDLETON FRED A	Director	Nov 17 '23	Buy	0.96	17,295	16,522	100,000	Nov 20 03:28 PM
MIDDLETON FRED A	Director	Nov 10 '23	Buy	0.92	2,705	2,489	82,705	Nov 13 04:39 PM
Jakeman David	VP of Finance and Accounting	Sep 28 '23	Sale	0.99	3,610	3,584	133,142	Sep 28 04:17 PM
MIDDLETON FRED A	Director	Sep 25 '23	Buy	0.98	20,000	19,636	80,000	Sep 26 03:58 PM
Andriole Michael T.	Chief Business Officer and CFO	May 18 '23	Buy	1.14	51,700	59,150	357,015	May 19 11:41 AM
Sherman Michael A.	Chief Executive Officer	May 12 '23	Buy	1.12	87,000	97,652	87,000	May 16 04:05 PM
DEMSKI MARTHA J	Director	May 10 '23	Buy	1.11	18,000	19,980	72,055	May 11 12:26 PM
Meyer Robert J.	Director	May 08 '23	Buy	1.14	8,750	9,975	35,150	May 10 12:51 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ADMA

Adma Biologics Inc

CMRX

Chimerix Inc

Upgrade your FINVIZ experience